These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 35522844)

  • 1. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
    Ashleigh T; Swerdlow RH; Beal MF
    Alzheimers Dement; 2023 Jan; 19(1):333-342. PubMed ID: 35522844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
    Reiss AB; Ahmed S; Dayaramani C; Glass AD; Gomolin IH; Pinkhasov A; Stecker MM; Wisniewski T; De Leon J
    Exp Gerontol; 2022 Jul; 164():111828. PubMed ID: 35508280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
    Wang W; Zhao F; Ma X; Perry G; Zhu X
    Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the neuronal synapse and challenges associated with the mitochondrial dysfunction in mild cognitive impairment and Alzheimer's disease.
    Verma H; Gangwar P; Yadav A; Yadav B; Rao R; Kaur S; Kumar P; Dhiman M; Taglialatela G; Mantha AK
    Mitochondrion; 2023 Nov; 73():19-29. PubMed ID: 37708950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
    Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mitochondrial secret(ase) of Alzheimer's disease.
    Young KJ; Bennett JP
    J Alzheimers Dis; 2010; 20 Suppl 2():S381-400. PubMed ID: 20442493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
    Bi D; Wen L; Wu Z; Shen Y
    Alzheimers Dement; 2020 Sep; 16(9):1312-1329. PubMed ID: 32543726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease.
    Sharma C; Kim S; Nam Y; Jung UJ; Kim SR
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?
    Mancuso M; Orsucci D; Siciliano G; Murri L
    Curr Alzheimer Res; 2008 Oct; 5(5):457-68. PubMed ID: 18855587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    Adiele RC; Adiele CA
    J Alzheimers Dis; 2016 Jul; 53(4):1257-70. PubMed ID: 27392851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria transfer as a potential therapeutic mechanism in Alzheimer's disease-like pathology.
    Mishra M; Raik S; Rattan V; Bhattacharyya S
    Brain Res; 2023 Nov; 1819():148544. PubMed ID: 37619852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β.
    Huang Z; Yan Q; Wang Y; Zou Q; Li J; Liu Z; Cai Z
    J Alzheimers Dis; 2020; 78(2):505-514. PubMed ID: 33044180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets.
    Fišar Z
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.
    Reddy PH; Manczak M; Mao P; Calkins MJ; Reddy AP; Shirendeb U
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S499-512. PubMed ID: 20413847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.